Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2230118rdf:typepubmed:Citationlld:pubmed
pubmed-article:2230118lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0949645lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0013879lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2230118lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2230118pubmed:issue10lld:pubmed
pubmed-article:2230118pubmed:dateCreated1990-12-12lld:pubmed
pubmed-article:2230118pubmed:abstractTextWe have analyzed the mechanisms by which IL-1, IL-2, and TNF regulate expression of IL-2R alpha chain in a rodent T cell line. All three cytokines induce detectable IL-2R alpha mRNA by themselves, but there is strong synergy between IL-1 or TNF, on the one hand, and IL-2, on the other. The earliest phase of induction by IL-1 is independent of protein synthesis. IL-1, but not TNF, also stimulates transient secretion of IL-2. This leads to an autocrine stimulation of a further increase in IL-2R alpha mRNA levels. When IL-2 secretion has dropped off, continued IL-2R alpha expression requires both IL-2 and IL-1. Most or all of this regulation is due to changes in the rate of transcription of the IL-2R alpha gene. The response to IL-1 and IL-2 depends on a segment in the IL-2R alpha 5' flanking region, upstream of all cis-acting regulatory elements previously identified in the human gene.lld:pubmed
pubmed-article:2230118pubmed:languageenglld:pubmed
pubmed-article:2230118pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2230118pubmed:statusMEDLINElld:pubmed
pubmed-article:2230118pubmed:monthNovlld:pubmed
pubmed-article:2230118pubmed:issn0022-1767lld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:NabholzMMlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:HonjoTTlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:KanamoriHHlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:SperisenPPlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:PlaetinckGGlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:CorthésyPPlld:pubmed
pubmed-article:2230118pubmed:authorpubmed-author:CombeM CMClld:pubmed
pubmed-article:2230118pubmed:issnTypePrintlld:pubmed
pubmed-article:2230118pubmed:day15lld:pubmed
pubmed-article:2230118pubmed:volume145lld:pubmed
pubmed-article:2230118pubmed:ownerNLMlld:pubmed
pubmed-article:2230118pubmed:authorsCompleteYlld:pubmed
pubmed-article:2230118pubmed:pagination3340-7lld:pubmed
pubmed-article:2230118pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:meshHeadingpubmed-meshheading:2230118-...lld:pubmed
pubmed-article:2230118pubmed:year1990lld:pubmed
pubmed-article:2230118pubmed:articleTitleControl of IL-2 receptor-alpha expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5' flanking region.lld:pubmed
pubmed-article:2230118pubmed:affiliationSwiss Institute for Experimental Cancer Research, Genetics Unit, Epalinges, Switzerland.lld:pubmed
pubmed-article:2230118pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2230118pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2230118lld:pubmed